| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 10/01/2009 | WO2009074300A3 Hedgehog pathway antagonists and therapeutic applications thereof |
| 10/01/2009 | US20090247767 Processes for preparing sunitinib and salts thereof |
| 10/01/2009 | US20090247595 Process for the preparation of tetrazolyl compounds |
| 10/01/2009 | US20090247591 Substituted cyclohexyldiamines |
| 10/01/2009 | US20090247547 Hydroxamate-based inhibitors of deacetylases b |
| 10/01/2009 | US20090247525 Sigma receptor inhibitors |
| 10/01/2009 | US20090247519 Amino-ethyl-amino-aryl (aeaa) compounds and their use |
| 10/01/2009 | US20090247513 Benzothiophene compounds having antiinfective activity |
| 10/01/2009 | US20090247510 Use Of Irbesartan For The Preparation Of Medicinal Products That Are Useful For Preventing or Treating Pulmonary Hypertension |
| 10/01/2009 | US20090247509 for treating central nervous system disorders such as psychological disorders, drug dependence and abuse, dyskinesia, dementia, anxiety disorders, sleep disorders and mood disorders |
| 10/01/2009 | US20090247508 Benzoimidazole Compounds |
| 10/01/2009 | US20090247474 3-Aminopyrrolidine Derivatives As Modulators Of Chemokine Receptors |
| 10/01/2009 | US20090242876 Carbazole compounds |
| 10/01/2009 | US20090242837 Charge transport compositions and electronic devices made with such compositions |
| 10/01/2009 | CA2719745A1 Novel p2x7r antagonists and their use |
| 10/01/2009 | CA2719743A1 Substituted cyclohexyldiamines |
| 10/01/2009 | CA2719477A1 Hydroxamate-based inhibitors of deacetylases b |
| 10/01/2009 | CA2718727A1 Heterocyclic compound |
| 10/01/2009 | CA2718618A1 Chemokine receptor modulators |
| 10/01/2009 | CA2716932A1 Aza-bicyclohexyl substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
| 09/30/2009 | EP2105441A1 Alanyl aminopeptidase and dipeptidylpeptidase IV dual inhibitors for the treatment of immunological, inflammatory, neuronal and other illnesses |
| 09/30/2009 | EP2105436A1 Lactam-containing compounds and derivatives thereof as factor XA inhibitors |
| 09/30/2009 | EP2105433A1 Modular scaffold for the design of specific molecules for the use as peptidomimetics and inhibitors of protein interaction |
| 09/30/2009 | EP2105164A1 Novel P2X7R antagonists and their use |
| 09/30/2009 | EP2104670A2 Novel triazinedione derivatives as gaba-b receptor modulators |
| 09/30/2009 | EP2104669A2 Inhibitors of akt activity |
| 09/30/2009 | EP1553089B1 Antagonist of melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredient |
| 09/30/2009 | EP1435944B1 4(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 09/30/2009 | CN101547918A Nitroderivatives as angiotensin II receptor antagonists |
| 09/30/2009 | CN101547917A Substituted pyrimidines and their use as JNK modulators |
| 09/30/2009 | CN101544614A Phosphodiesterase III inhibitor, method for preparing same and medicinal application thereof |
| 09/30/2009 | CN101544592A N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them |
| 09/29/2009 | US7595343 Inhibitors of histone deacetylase |
| 09/29/2009 | US7595339 Such as N-(4-Fluoro-benzyl)-4-(3-phenyl-indole-1-sulfonyl)-benzamide; Cannabinoid-1 (CB1) receptor; dietetics |
| 09/29/2009 | US7595336 Isatine derivatives with neurotrophic activity |
| 09/29/2009 | US7595329 4-{[4-({[(3-isopropyl-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)carbonyl]amino}methyl)piperidin-1-yl]methyl}tetrahydro-2H-pyran-4-carboxylic acid; serotonin receptor agonist; gastroesophageal reflux disease, analgesic, cognition activator; less toxicity, good absorption, and metabolic stability |
| 09/29/2009 | US7595324 Substituted thieno[3,2-D]pyrimidines as HIV inhibitors |
| 09/29/2009 | US7595321 Useful for the prevention and/or treatment of cognitive disorders; 3-Amino-N-(2-cyanoethyl)-6-[4-(pyrrolidin-1-ylsulfonyl)phenyl]pyrazine-2-carboxamide, for example |
| 09/29/2009 | US7595319 Compounds having selective inhibiting effect at GSK3 |
| 09/29/2009 | US7595317 Antiarthritic agents; rheumatoid and osteoarthritis; corneal, epidermal, or gastric ulceration; tumor metastasis or invasion; periodontal disease; and bone disease; 4-[(2-methyl-4-quinolinyl)methoxy]-N-(1,3,5-trioxo-2,4-diazaspiro[5.5]undec-7-yl)benzamide trifluoroacetate, for example |
| 09/24/2009 | WO2009117489A1 Dexlansoprazole process and polymorphs |
| 09/24/2009 | WO2009117269A1 Substituted 4-hydroxypyrimidine-5-carboxamides |
| 09/24/2009 | WO2009117109A1 Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
| 09/24/2009 | WO2009115874A2 Novel heterocyclic compounds, pharmaceutical compositions containing them and processes for their preparation |
| 09/24/2009 | WO2009115685A1 Novel 3-aminoalkyl-1,3-dihydro-2h-indol-2-one derivatives, preparation thereof and therapeutic use thereof. |
| 09/24/2009 | WO2009115585A1 Catalyzed carbonylation in the synthesis of angiotensin ii antagonists |
| 09/24/2009 | WO2009115515A1 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-ht6 antagonists |
| 09/24/2009 | WO2009115486A1 Triazole amide derivatives for use in therapy |
| 09/24/2009 | WO2009115427A1 Pyrrolidinyl derivatives and uses thereof |
| 09/24/2009 | WO2009115213A1 (pyrazolyl carbonyl)imidazolidinone derivatives for the treatment of retroviral diseases |
| 09/24/2009 | WO2009114994A1 The use of the pyridazinone derivatives for the manufacture of medicament for anti-tumour |
| 09/24/2009 | WO2009072137A3 Process for pure irbesartan |
| 09/24/2009 | WO2009057139A3 Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents |
| 09/24/2009 | WO2009053993A3 Process for preparation of novel salt of voriconazole oxalate form-c |
| 09/24/2009 | WO2009032668A3 2 -biphenylamino-4 -aminopyrimidine derivatives as kinase inhibitors |
| 09/24/2009 | WO2009005674A3 Novel hiv reverse transcriptase inhibitors |
| 09/24/2009 | US20090240060 Process for the preparation of pure irbesartan |
| 09/24/2009 | US20090239982 Ultraviolet Absorbent and Heterocyclic Compound |
| 09/24/2009 | US20090239877 Novel 1,2,4-triazole derivatives and process of manufacturing thereof |
| 09/24/2009 | US20090239876 Substituted 4-Hydroxypyrimidine-5-Carboxamides |
| 09/24/2009 | US20090239866 Peptide deformylase inhibitors |
| 09/24/2009 | US20090239845 Pyrazole compounds as prostaglandin receptors ligands |
| 09/24/2009 | DE102008015033A1 Substituierte (Pyrazolyl-carbonyl)imidazolidinone und ihre Verwendung Substituted (pyrazolyl-carbonyl) imidazolidinones and their use |
| 09/24/2009 | CA2719068A1 Catalyzed carbonylation in the synthesis of angiotensin ii antagonists |
| 09/24/2009 | CA2718936A1 Novel heterocyclic compounds and uses therof |
| 09/24/2009 | CA2718736A1 Pyrrolidinyl derivatives and uses thereof |
| 09/24/2009 | CA2718693A1 Substituted pyrazolamides and the use thereof |
| 09/24/2009 | CA2718685A1 (pyrazolyl carbonyl)imidazolidinone derivatives for the treatment of retroviral diseases |
| 09/24/2009 | CA2718528A1 Substituted 4-hydroxypyrimidine-5-carboxamides |
| 09/24/2009 | CA2718264A1 Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 |
| 09/24/2009 | CA2717922A1 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-ht6 antagonists |
| 09/24/2009 | CA2717578A1 Dexlansoprazole process and polymorphs |
| 09/24/2009 | CA2716035A1 Novel 3-aminoalkyl-1,3-dihydro-2h-indol-2-one derivatives, preparation thereof and therapeutic use thereof |
| 09/23/2009 | EP2103610A1 The salts of imidazol-5-carboxylic acid derivatives, preparation methods and use therrof |
| 09/23/2009 | EP2103609A1 Catalyzed carbonylation in the synthesis of angiotensin ii antagonists |
| 09/23/2009 | EP2103603A1 Method for producing pyrrolidine compound |
| 09/23/2009 | EP2102195A1 Crystal modifications -3- (1h-ind0l-3-yl) -4- [2- (4-methyl-piperazin-1-yl) -quinazolin-4-yl]-pyrrole-2, 5-d ione |
| 09/23/2009 | EP2102190A1 Compounds and compositions as kinase inhibitors |
| 09/23/2009 | EP2102189A2 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 09/23/2009 | EP2102171A1 New pyridazine derivatives with mch antagonistic activity and medicaments comprising these compounds |
| 09/23/2009 | EP2102170A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 09/23/2009 | EP2102169A1 Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| 09/23/2009 | EP2102168A1 Acylaminopyrazoles for treating cardiovascular diseases |
| 09/23/2009 | EP2102157A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives |
| 09/23/2009 | EP1467989B1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection |
| 09/23/2009 | EP0946508B1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS |
| 09/23/2009 | CN101541789A Hydantoin derivatives used as mmp inhibitors |
| 09/23/2009 | CN101538246A Pyrimidine amide compounds as pgds inhibitors |
| 09/23/2009 | CN101538245A One-class pyridazinone compounds and preparation method and application thereof |
| 09/23/2009 | CN101538244A 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity |
| 09/23/2009 | CN101538236A Method for synthesizing lauroyl-prolyl amino acid methyl ester as novel transdermal enhancer and applications thereof |
| 09/22/2009 | US7592451 Glyceraldehyde 3-phosphate dehydrogenase (GADPH) inhibitors and screening compounds |
| 09/22/2009 | US7592450 used to inhibit proliferative conditions, such as cancer and psoriasis, with improved bioavailability and stability |
| 09/22/2009 | US7592419 Macrocyclic inhibitors of hepatitis C virus NS3-serine protease |
| 09/22/2009 | US7592361 Indole acetic acid derivatives and their use as pharmaceutical agents |
| 09/22/2009 | US7592356 and geranylgeranyltransferase inhibitor; 3-chloromethyl-4-cyanobenzyl-5 methyl triazole; antitumor agents; prevent membrane attachment of protein p21ras and block aberrant growth of ras-transformed tumors; capable to inhibit prenylation of Ras proteins, both at enzymatic and cellular level |
| 09/22/2009 | US7592349 Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors |
| 09/22/2009 | US7592340 Quinoxalines useful as inhibitors of protein kinases |
| 09/22/2009 | US7592338 (1-phenyl-5-propyl-1H-pyrazol-4-yl)-(3-amino-N-cyclopropyl-4-methyl-benzamide)-amine; p38 mitogen-activated protein kinase inhibitor; reduced levels of TNF- alpha expression; antiinfammatory agent: rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease |
| 09/22/2009 | CA2398274C Adenosine receptor modulators |